Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia

医学 头孢唑林 菌血症 外科 抗生素 内科学 败血症 并发症 抗菌剂 抗菌剂
作者
The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Group
出处
期刊:The New England Journal of Medicine [Massachusetts Medical Society]
卷期号:394 (23): 2329-2339 被引量:19
标识
DOI:10.1056/nejmoa2506905
摘要

Background Staphylococcus aureus bacteremia is associated with high mortality. Whether cefazolin or an antistaphylococcal penicillin should be preferred for the treatment of methicillin-susceptible S. aureus bacteremia is unclear. Methods In an ongoing international Bayesian adaptive platform trial, we conducted an open-label, randomized comparison of cefazolin with an antistaphylococcal penicillin (flucloxacillin or cloxacillin) in adult patients with penicillin-resistant, methicillin-susceptible S. aureus bacteremia. The primary outcome, which was evaluated with a hierarchical Bayesian logistic-regression model, was death from any cause within 90 days after enrollment in the platform. We assessed the posterior probability of the noninferiority of cefazolin to flucloxacillin or cloxacillin (with the criterion for noninferiority prespecified as an adjusted odds ratio of <1.2, which approximates an absolute difference in mortality of <2.5 percentage points if mortality in the antistaphylococcal-penicillin group is 15%), as well as the posterior probability of superiority (with the criterion of an adjusted odds ratio of <1.0). Secondary safety outcomes included the development of acute kidney injury within 14 days. Research Summary Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia Results This domain of the ongoing trial was conducted between February 17, 2022, and August 7, 2024, by which time the criterion for noninferiority had been met. Mortality at 90 days among adults who could be evaluated was 15.0% (97 deaths among 645 patients) in the cefazolin group and 17.0% (109 deaths among 642 patients) in the antistaphylococcal-penicillin group (adjusted odds ratio, 0.81; 95% credible interval, 0.59 to 1.12; probability of noninferiority, 99.2%; probability of superiority, 89.8%). Acute kidney injury occurred in 92 of 660 patients (13.9%) in the cefazolin group, as compared with 127 of 648 (19.6%) in the antistaphylococcal-penicillin group (adjusted odds ratio, 0.67; 95% credible interval, 0.50 to 0.89; probability of superiority, 99.7%). Conclusions In patients with methicillin-susceptible S. aureus bacteremia, cefazolin was noninferior to flucloxacillin or cloxacillin with respect to 90-day mortality and was associated with a lower incidence of acute kidney injury. (Funded by the National Health and Medical Research Council and others; SNAP ClinicalTrials.gov number, NCT05137119 .)
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
曜骅完成签到,获得积分10
刚刚
李萌完成签到,获得积分10
刚刚
深情安青的应助被Afterlife34采纳,获得10
1秒前
wfy完成签到,获得积分10
1秒前
1秒前
2秒前
大个的应助被小小的飞机采纳,获得10
2秒前
2秒前
搞怪的老九完成签到,获得积分0
2秒前
titijaychou发布了新的文献求助10
2秒前
3秒前
3秒前
3秒前
JuPP完成签到,获得积分10
3秒前
易昭华完成签到,获得积分10
3秒前
leotao发布了新的文献求助10
3秒前
3秒前
haoyun完成签到,获得积分10
4秒前
1111完成签到,获得积分10
4秒前
七星嘿咻完成签到,获得积分0
4秒前
科研通AI6.4的应助被尹丹采纳,获得10
4秒前
minminzi完成签到,获得积分10
4秒前
4秒前
5秒前
雪白的白桃完成签到,获得积分10
5秒前
bkagyin的应助被李晓彤采纳,获得10
5秒前
后来吧没事了完成签到,获得积分10
5秒前
6秒前
PPPP发布了新的文献求助10
6秒前
11完成签到,获得积分10
8秒前
失物爱发布了新的文献求助10
8秒前
便便民工发布了新的文献求助10
8秒前
eF完成签到,获得积分10
8秒前
8秒前
cookie完成签到,获得积分20
8秒前
快乐十一给快乐十一的求助进行了留言
8秒前
9秒前
CYH发布了新的文献求助10
9秒前
9秒前
可爱的函函的应助被OswaldYX采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180488
求助须知:如何正确求助?哪些是违规求助? 9570437
关于积分的说明 21812406
捐赠科研通 7776516
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557516
邀请新用户注册赠送积分活动 2479162